Lantern Pharma Announces Abstract on Effectiveness of LP-284 in Hematologic Cancers Accepted for Presentation at the 63rd American Society of Hematology (ASH) Annual Meeting
Stock Information for Lantern Pharma Inc.
Loading
Please wait while we load your information from QuoteMedia.